Company / Revenue per Share
PTC Therapeutics, Inc. Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$22.27
FY2025
5-year range
$4.40 / $22.27
FY2021-FY2025
Trend
+109.0%
vs FY2024
Sector context
#26 of 154
Health Care
What the data says
PTC Therapeutics, Inc.'s revenue per share of $22.27 is higher than 83% of companies in the Health Care sector (FY2025). Revenue per Share has fluctuated over the past 10 years, ranging from $2.44 in FY2016 to $22.27 in FY2025.
Based on SEC 10-K filings.
22.27 in FY2025 with a 5-year CAGR of +39.1%. Top quartile in the Health Care sector.
Improved from $12.83 to $22.27 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +60.6%
- 5-Year CAGR
- +39.1%
- 10-Year CAGR
- -
Sector benchmark
+115.1% above sector average
Key checks
Key Insights
- In FY2025, revenue per share increased 109.0% year-over-year.
- Ranks #26 out of 154 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.95 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $22.27 | +109.0% |
| FY2024 | $10.66 | -16.9% |
| FY2023 | $12.83 | +138.6% |
| FY2022 | $5.38 | +22.1% |
| FY2021 | $4.40 | +3.0% |
| FY2020 | $4.27 | -18.0% |
| FY2019 | $5.22 | -18.0% |
| FY2018 | $6.36 | +11.8% |
| FY2017 | $5.69 | +133.3% |
| FY2016 | $2.44 | +118.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026